JYNNEOS vaccination provides protection against mpox

Corporate businessmen working on tablet at office

Among men aged 18 to 49 years who are eligible for the JYNNEOS vaccine, mpox incidence is considerably higher among unvaccinated persons versus those who received one or two vaccine doses, according to research published in the Dec. 9 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

Research explores early predictors of children’s language delays

Previous article

Old trees may handle climate extremes better

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations